Study: Cholesterol-Lowering Drugs Don’t Offset Healthy Choices
Within the medical field, it is often assumed that patients view cholesterol-lowering medications (or statins) as a license to eat whatever they like - they figure their medication has them covered, so a steak here and there won't hurt.
World’s Largest Cholesterol-Lowering Trial Reveals Massive Benefits for High-Risk Patients
Around a third of all heart attacks and strokes can be avoided in people at risk of vascular disease by using statin drugs to lower blood cholesterol levels – irrespective of the person’s age or sex, and even if their cholesterol levels do not seem high.
New Cholesterol Disorder Discovered – As Predicted From Gene’s Role
A team lead by UCSF medical researchers has discovered a new disorder that can cause severely elevated blood cholesterol levels and may affect several hundred thousand people in the U.S. and Europe to varying degrees. The malady is caused by a single gene defect.
Phenolic Compounds May Explain Mediterranean Diet Benefits
Phenolic compounds in olive oil, which have antioxidant, anti-inflammatory and anti-clotting properties, may explain cardiovascular health benefits associated with the so-called Mediterranean Diet, according to a new study.
High Hostility May Predict Heart Disease More Than Other Risk Factors Such As Cholesterol
Hostility may predict heart disease more often than traditional coronary heart disease risk factors like high cholesterol, cigarette smoking and weight.
ACP Says That Many Diabetics Should Be Taking Statins
ACP: All people with type 2 diabetes mellitus and coronary artery disease, and all people with diabetes and any other risk for cardiovascular disease, should be taking cholesterol-lowering drugs called statins.
Product Used to Lower Cholesterol Works No Better Than Placebo
A natural extract often favored by health-conscious Americans as an alternative to manufactured drugs in lowering cholesterol has turned out to be no more effective than a placebo.
Exercise Shown to Have Positive Effect On Cholesterol
For the first time, Duke University Medical Center researchers have demonstrated that exercise -- without accompanying weight loss -- has a positive impact on improving cholesterol levels.
Study: Cholesterol-Lowering Foods Most Effective When Combined
Cholesterol-lowering foods such as soy protein, almonds, plant sterol enriched margarines, oats and barley may reduce cholesterol levels more effectively when eaten in combination.
Statins May Simulate Stem Cells For Heart Repair
The drug pravastatin, which is used widely to decrease high cholesterol, may provide a previously unknown cardiovascular benefit in addition to lowering lipids.
Diabetes Medication May Help Slow Plaque Build-up in Coronary Arteries
A comparison of two types of medications to treat type 2 diabetes finds that pioglitazone is more effective at lowering the rate of progression of plaque build-up in the coronary arteries than glimepiride, according to a study in the April 2 issue of JAMA.
High Cholesterol Predicts Lower Mortality in Dialysis Patients But Is Not Protective
Kidney dialysis patients with higher cholesterol levels die at a lower rate than those with lower cholesterol levels.
Nearly Half of People Who Need Cholesterol Treatment Don’t Get It
Even though treatment for cholesterol disorders can reduce the risk of heart and blood vessel disease by about 30 percent over five years, many at-risk people aren't getting adequate treatment.
Onion Extract Lowers High Blood Glucose and Cholesterol Levels When Combined with Metformin
According to a new study, the extract of onion bulb strongly lowered high blood glucose and total cholesterol levels when given with the antidiabetic...
Adopting Healthy Habits in Youth Associated with More Favorable Cholesterol Levels in Adulthood
Lifestyle changes between childhood and adulthood appear associated with whether an individual will maintain, improve or develop high-risk cholesterol levels.
Mixed Results For Weight Loss Drug on Slowing Progression of Coronary Disease
The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new study in the April 2 issue of JAMA.
